SCM
QNRX

Stonepine Capital Management’s Quoin Pharmaceuticals QNRX Stock Holding History

Stonepine Capital Management’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$966K Buy
199,486
+146,026
+273% +$788K 0.54% 44
2026
Q1 		$353K Sell
53,460
-24,729
-32% -$224K 0.14% 61
2025
Q4 		$1.13M Buy
+78,189
New +$1.06M 0.82% 33

Other funds holding QNRX

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Stonepine Capital Management's QNRX Position: Q2 2026 in Review

Stonepine Capital Management increased its Quoin Pharmaceuticals (QNRX) stake by 273% in Q2 2026, buying an estimated $788K and bringing the position to 199,486 shares worth $966K. The position accounts for 0.54% of the portfolio, ranked #44.

Stonepine Capital Management first reported a position in QNRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.13M in Q4 2025. 20 funds tracked by Wall St. Rank hold QNRX as of Q2 2026.

  • Stonepine Capital Management held 199,486 shares of Quoin Pharmaceuticals worth $966K as of Q2 2026.
  • Stonepine Capital Management bought 146,026 Quoin Pharmaceuticals shares in Q2 2026, an estimated $788K.
  • Quoin Pharmaceuticals made up 0.54% of Stonepine Capital Management's portfolio in Q2 2026, its #44 holding.
  • Stonepine Capital Management first reported a position in Quoin Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Stonepine Capital Management's Quoin Pharmaceuticals position peaked at $1.13M in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2026.

Based on Stonepine Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.